1. Home
  2. SILA vs EVO Comparison

SILA vs EVO Comparison

Compare SILA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILA
  • EVO
  • Stock Information
  • Founded
  • SILA 2013
  • EVO 1993
  • Country
  • SILA United States
  • EVO Germany
  • Employees
  • SILA N/A
  • EVO N/A
  • Industry
  • SILA
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SILA
  • EVO Health Care
  • Exchange
  • SILA NYSE
  • EVO Nasdaq
  • Market Cap
  • SILA 1.3B
  • EVO 1.5B
  • IPO Year
  • SILA N/A
  • EVO 2021
  • Fundamental
  • Price
  • SILA $24.23
  • EVO $4.11
  • Analyst Decision
  • SILA Strong Buy
  • EVO Buy
  • Analyst Count
  • SILA 3
  • EVO 2
  • Target Price
  • SILA $28.67
  • EVO $5.90
  • AVG Volume (30 Days)
  • SILA 332.8K
  • EVO 184.0K
  • Earning Date
  • SILA 02-21-2025
  • EVO 11-06-2024
  • Dividend Yield
  • SILA 2.75%
  • EVO N/A
  • EPS Growth
  • SILA N/A
  • EVO N/A
  • EPS
  • SILA 0.37
  • EVO N/A
  • Revenue
  • SILA $186,225,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • SILA N/A
  • EVO $3.89
  • Revenue Next Year
  • SILA $4.55
  • EVO $9.65
  • P/E Ratio
  • SILA $65.53
  • EVO N/A
  • Revenue Growth
  • SILA N/A
  • EVO N/A
  • 52 Week Low
  • SILA $20.20
  • EVO $2.85
  • 52 Week High
  • SILA $26.75
  • EVO $8.39
  • Technical
  • Relative Strength Index (RSI)
  • SILA N/A
  • EVO 42.87
  • Support Level
  • SILA N/A
  • EVO $4.00
  • Resistance Level
  • SILA N/A
  • EVO $4.63
  • Average True Range (ATR)
  • SILA 0.00
  • EVO 0.14
  • MACD
  • SILA 0.00
  • EVO -0.04
  • Stochastic Oscillator
  • SILA 0.00
  • EVO 16.88

About SILA SILA REALTY TRUST INC

Sila Realty Trust Inc is a real estate investment trust. Its investment objective is to pay regular cash distributions to stockholders and to preserve, protect, and return capital contributions to stockholders. The company owns and manages healthcare assets. The company generates revenue from real estate investments in healthcare properties.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: